Stalk antibodies provide flu protection in humans: study

    Source: Xinhua| 2019-06-05 01:58:10|Editor: yan
    Video PlayerClose

    CHICAGO, June 4 (Xinhua) -- An international team of researchers is now a step closer to developing a universal flu vaccine after proving that targeting a specific area of the flu virus does protect humans.

    For the study, the researchers from the University of Michigan, the Icahn School of Medicine at Mount Sinai and other institutions looked at naturally occurring influenza cases in a cohort investigators have followed in Nicaragua for years.

    After one member in a household was determined to have the flu, the researchers took blood samples to test the rest of the household. They looked at who was infected with the virus antibodies and who got sick.

    Traditionally, an antibody concentration of 1:40, measured in the hemagglutination inhibition assay, has been used as a 50-percent correlate of protection from clinical disease, which means that half of the people who have those levels will be protected from influenza.

    In the study, the researchers found a similar protection, corroborating the idea that the field study design is sound to examine correlates of protection. They also found that a rise of four times in the amount of stalk antibody levels correlated with 42-percent reduction in influenza infection.

    "We were able to show that stalk antibodies do correlate with protection," said Aubree Gordon, a professor of epidemiology at UM's School of Public Health. "That is great news as it supports the idea that stalk antibodies may be able to provide protection against influenza and could enable scientists to design a broader, more effective influenza vaccine."

    The flu virus is covered with two types of proteins: hemagglutinin and neuraminidase. The current flu vaccine targets the head of the hemagglutinin, a lollipop-like structure, which is the part that changes most often. If they target the stem of the hemagglutinin, instead of the head, it would allow them to prevent a wider range of flu viruses, as these do not change as often.

    "Our research is the first to demonstrate that scientists are right in attempting to develop antibodies that target this specific location as a novel universal influenza virus vaccine candidate," Gordon said.

    The study also showed new tests can be used in flu research.

    "An additional finding of this study is that ELISA based readouts can be used as independent correlate of protection," said Florian Krammer, a professor of microbiology at the Icahn School of Medicine at Mount Sinai. "ELISAs are binding assays and do not indicate functionality, but are much easier and quicker than functional assays."

    "While there are caveats and further studies needed, this is good news for the development of stalk-based universal influenza virus vaccines," Krammer said. "It seems we are on the right track."

    The study has been published in the June issue of Nature Medicine.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011105521381168111
    主站蜘蛛池模板: 欧美亚洲国产一区二区三区| 偷看农村妇女牲交| 又爽又黄又无遮挡网站| 人人澡人人澡人人澡| 亚洲国产欧美无圣光一区| 五月天中文在线| 中文天堂最新版www官网在线| ts人妖系列在线专区| 69av在线视频| 美女的大胸又黄又www又爽| 波多野结无码高清中文| 日本黄页网站免费| 好男人看的视频2018免费| 国产精品无码MV在线观看| 国产又粗又长又硬免费视频| 动漫精品一区二区三区四区| 亚洲成av人片在线观看无码| 久久久亚洲欧洲日产国码农村| a级毛片视频免费观看| 黄色大片网站在线观看| 男人的天堂色偷偷之色偷偷| 最近中文国语字幕在线播放| 性做久久久久久久| 国产污片在线观看| 再深点灬舒服灬太大了老板| 亚洲av日韩精品久久久久久久| 中文字幕日韩一区二区不卡| 2o18国产大陆天天弄| 翁止熄痒禁伦短文合集免费视频 | 114级毛片免费观看| 羞羞答答xxdd影院欧美| 欧美成人中文字幕dvd| 性高湖久久久久久久久aaaaa| 国产精品欧美成人| 午夜免费福利在线| 九九免费久久这里有精品23| jlzz大全高潮多水老师| 被夫上司连续侵犯七天终于| 欧美日韩国产高清视频| 影音先锋女人aa鲁色资源| 国产在线国偷精品产拍|